INDIANAPOLIS, Dec. 1 /PRNewswire-FirstCall/ -- The educational resource, "The Value of Medicine, Improving Health... Improving Life," created by Lilly USA (NYSE: LLY), is now available at www.lillyforbetterhealth.com/value_of_medicine.jsp. The booklet supports Lilly's commitment to providing "Answers That Matter" and encourages an open dialogue with patients, providers, payers and the public about pharmaceutical industry practices.
"Today, Lilly and others in health care face tough questions about access to care, managing costs, drug safety and the best ways to fight disease," said David Ricks, president, Lilly USA. "Providing answers requires that we understand diverse perspectives, offer reliable information and keep the focus on what's best for patients. This booklet was created to build understanding between Lilly and its partners in the health care system as we pursue a shared goal of improving health outcomes for patients."
This is the fourth edition of the resource, which covers topics including(1):
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.
(1) The Value of Medicine, Improving Health...Improving Life: Data on file, Lilly USA, LLC, MG59303.
(2) Department of Health and Human Services, Centers for Medicare and Medicaid Services. 2007 National Health Expenditure data. Available at: http://www.cms.hhs.gov/NationalHealthExpendData/downloads/tables.pdf. Accessed May 14, 2009.
(3) Insurance Journal. Study: High Prescription Drug Costs Help Lower Other Medical Costs. Available at: http://www.insurancejournal.com/news/national/2008/05/22/90245.htm. Accessed November 19, 2009.
(4) PhRMA Annual Survey: PhRMA Member Company Patient Assistance Programs: Data on file, Lilly USA, LLC, B2B20090701B.
(5) Centers for Disease Control. Counterfeit Drugs and Travel. Available at: http://wwwnc.cdc.gov/travel/content/counterfeit-drugs.aspx. Accessed November 19, 2009.
(6) Consumeraffairs.com. Report: Importing Drugs Wouldn't Save Money. Available at http://www.consumeraffairs.com/news04/rx_reimport_report.html. Accessed November 10, 2009.
(7) Lichtenberg FR. The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982-2001. NBER Working Paper No. 9754. Cambridge, MA: National Bureau of Economic Research; June 2003.
(8) Medtap International. The Value of Investment in Health Care: Better Care, Better Lives. Available at:
http://www.aha.org/aha/research-and-trends/AHA-policy-research/VoIHC-more-resources.html. Accessed November 19, 2009.
(9) R&D Ratios & Budgets. Libertyville, IL: Schonfeld & Associates, Inc.; June 2008.
(10) Department of Health and Human Services. NIH Response to the Conference Report Request for a Plan to Ensure Taxpayers' Interests are Protected. Available at: http://www.nih.gov/news/070101wyden.htm. Accessed November 19, 2009.
(11) IMS Health, IMS Integrated Promotional Services, June 2009: Data on file, Lilly USA, LLC, B2B20090701E.
(12) Pharmaceutical Research and Manufacturers of America. Pharmaceutical Industry Profile 2009. Washington, D.C.: PhRMA; March 2009.
(13) The U.S. Food and Drug Administration. The Impact of Direct-To-Consumer
Advertising. Available at: http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm143562.htm. Accessed November 19, 2009.
SOURCE Eli Lilly and Company
|SOURCE Eli Lilly and Company|
Copyright©2009 PR Newswire.
All rights reserved